Company: ABBV
Filing Date: 2025-02-14
Form Type: 10-K
Source: 0001551152-25-000020
Chunk: 348

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: 10-K
Item: Item 8
Chunk 348
---
%5.1 %2.7 %For the December 31, 2024 post-retirement health care obligations remeasurement, the company assumed a 6.6% pre-65 (2.0% post-65) annual rate of increase in the per capita cost of covered health care benefits. The pre-65 rate was assumed to decrease gradually to 4.5% (1.8% post-65) in 2033 and remain at that level thereafter. For purposes of measuring the 2024 post-retirement health care costs, the company assumed a 7.4% pre-65 (2.1% post-65) annual rate of increase in the per capita cost of covered health care benefits. The pre-65 rate was assumed to decrease gradually to 4.5% (1.8% post-65) for 2032 and remain at that level thereafter.

2024 Form 10-K   |  86

Defined Benefit Pension Plan AssetsBasis of fair value measurementas of December 31 (in millions)2024Quoted prices in active markets for identical assets (Level 1)Significant other observable inputs (Level 2)Significant unobservable inputs (Level 3)EquitiesU.S. large cap(a)$1,131 $1,131 $— $— U.S. mid cap(b)176 176 — — International(c)408 408 — — Fixed income securitiesU.S. government securities(d)414 18 396 — Corporate debt instruments(d)609 29 580 — Non-U.S. government securities(d)346 183 163 — Other(d)20 15 5 — Absolute return funds(e)176 82 94 — Other(f)351 350 1 — Total$3,631 $2,392 $1,239 $— Total assets measured at NAV6,920 Fair value of plan assets$10,551 Basis of fair value measurementas of December 31 (in millions)2023Quoted prices in active markets for identical assets (Level 1)Significant other observable inputs (Level 2)Significant unobservable inputs (Level 3)EquitiesU.S. large cap(a)$1,018 $1,018 $— $— U.S. mid cap(b)173 173